Enhancing Healing in Oculoplastic Surgeries: The Efficacy of Hyperbaric Oxygen Therapy for Dermal Fat, Mucosal, and Skin Grafts
Author: İsmail Uyanık
Base Hospital / Institution: University of Health Sciences, Beyoglu Eye Training and Research Hospital
ePoster presentation
Abstract ID: 24-367
Purpose
This study investigates the efficacy of hyperbaric oxygen therapy (HBOT) in tissue repair after oculoplastic surgeries using different types of grafts. The aim is to detail the indications, clinical features, and progression of cases undergoing HBOT after various oculoplastic procedures.
Methods
A retrospective analysis was conducted on the records of 11 cases who received HBOT postoperatively in our clinic from January 2022 to May 2024. Data collected included demographic characteristics, comorbidities, etiologies, surgical treatments, graft types, indications for HBOT, and follow-up durations.
Results
The study comprised 5 female and 6 male cases, with a mean age of 49.9±12.0 years. Comorbidities included diabetes (1), hypertension (1 case), and smoking (2 cases). Etiologies involved sphere exposure in the anophthalmic socket (5), surgically induced necrotizing scleritis (SINS) (1), cicatricial entropion from chemical burn (1), conjunctival-scleral necrosis post-evisceration due to pseudomonas endophthalmitis (1), lower lid tissue loss from trauma (1 case), dermolipoma from Goldenhar syndrome (1), and a lower eyelid mass (1 case). Various grafts were utilized: dermal fat graft (3), buccal mucosa (BM) graft (1), and cryopreserved umbilical amniotic membrane (cUAM) graft (1) for sphere exposure cases. cUAM also used in SINS and cicatricial entropion cases. Intravenous antibiotics and debridement were performed for conjunctival-scleral necrosis. Postauricular skin grafts were used for eyelid tissue loss and lower lid mass excision, with BM graft applied for dermolipoma excision. HBOT was administered for 10 sessions in 6 cases and 20 sessions in 5 cases. The mean recovery time was 60.6±37.2 days. Graft viability and satisfactory functional and cosmetic outcomes were observed in all cases at the last follow-up, with a mean follow-up period of 276±217 days.
Conclusion
HBOT has long been used to treat and prevent tissue ischemia, necrosis, and fibrosis.This study suggests that HBOT significantly enhances tissue healing in reconstructive surgeries involving skin, mucosa, and dermal fat grafts
Additional Authors
| First name | Last name | Base Hospital / Institution |
|---|---|---|
| Husna | Topcu | University of Health Sciences, Beyoglu Eye Training and Research Hospital |
| Ayse | Cetin Efe | University of Health Sciences, Beyoglu Eye Training and Research Hospital |
| Mehmet Goksel | Ulas | University of Health Sciences, Beyoglu Eye Training and Research Hospital |
| Fatma | Poslu Karademir | University of Health Sciences, Beyoglu Eye Training and Research Hospital |
| Kubra | Serefoglu Cabuk | University of Health Sciences, Cam and Sakura City Hospital |
